1. Hydroxyapatite-poly(vinyl alcohol) core-shell nanoparticles for dual delivery of methotrexate and gemcitabine for bone cancer treatment
   S. Ram Prasad et al, 2019, Journal of Drug Delivery Science and Technology CrossRef
2. Advances in systemic therapy for malignant mesothelioma: future perspectives
   Navid Sobhani et al, 2017, Future Oncology CrossRef
3. CKS protein overexpression renders tumors susceptible to a chemotherapeutic strategy that protects normal tissues
   John Tat et al, 2017, Oncotarget CrossRef
4. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
   Isabelle Opitz et al, 2020, European Journal of Cardio-Thoracic Surgery CrossRef
5. Coactive chemoradiotherapy using polysaccharides- and synthetic polymers-based hydrogels for cancer treatment: A review
   Mozhdeh Dolati et al, 2024, Carbohydrate Polymer Technologies and Applications CrossRef
6. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
   Arnaud Scherpereel et al, 2020, European Respiratory Journal CrossRef
7. Macromolecular Bipill of Gemcitabine and Methotrexate Facilitates Tumor-Specific Dual Drug Therapy with Higher Benefit-to-Risk Ratio
   Manasmita Das et al, 2014, Bioconjugate Chemistry CrossRef
8. Self-Delivery Nanoparticles of Amphiphilic Methotrexate-Gemcitabine Prodrug for Synergistic Combination Chemotherapy via Effect of Deoxyribonucleotide Pools
   Yao Wang et al, 2016, Bioconjugate Chemistry CrossRef